Single-Dose xRNA Enables Weeks of Sustained Incretin Therapy
1:45 pm - Thursday 29th October 2026
- Engineering xRNA to give weeks of GLP-1 pharmacology from one injection
- Optimising RNA chemistry to increase expression potency and durability beyond conventional mRNA
- Flattening peak-and-trough exposure to improve tolerability and adherence
